Bilcare Limited increases stake in Caprihans India to 62.92%
Bilcare Limited, the promoter of Caprihans India Limited, converted 14,40,000 warrants into equity shares across three tranches between May 28 and May 30, 2026. This conversion increased the promoter's stake from 59.56% to 62.92%. The warrants were converted at a price of ₹200 per share, comprising a face value of ₹10 and a premium of ₹190.

*this image is generated using AI for illustrative purposes only.
Bilcare Limited, the promoter of Caprihans India Limited , has increased its shareholding to 62.92% following the conversion of 14,40,000 warrants into equity shares. The conversion took place in three tranches on May 28, May 29, and May 30, 2026, as part of the financial year 2026-27. The warrants were converted at a price of ₹200 per share, comprising a face value of ₹10 and a premium of ₹190.
Shareholding Details
The conversion of warrants has significantly altered the promoter's holding pattern in the company. Prior to the first tranche of conversion on May 28, 2026, Bilcare Limited held 94,78,325 equity shares, representing 59.56% of the total equity share capital. Following the final tranche on May 30, 2026, the holding increased to 1,09,18,425 equity shares, or 62.92% of the total equity share capital.
The following table outlines the changes in shareholding across the three conversion tranches:
| Sr. No. | Conversion Tranche | Date of Allotment | Equity Shares Prior | % Prior | Equity Shares Post | % Post |
|---|---|---|---|---|---|---|
| 1 | First Tranche | 28/05/2026 | 94,78,325 | 59.56 | 99,98,325 | 60.84 |
| 2 | Second Tranche | 29/05/2026 | 99,98,325 | 60.84 | 105,18,325 | 62.04 |
| 3 | Third Tranche | 30/05/2026 | 105,18,325 | 62.04 | 109,18,425 | 62.92 |
Warrant Conversion Breakdown
Bilcare Limited initially held 20,20,000 convertible warrants. The company exercised its right to convert these instruments into equity shares in three separate installments. The first tranche involved the conversion of 5,20,000 warrants on May 28, 2026. The second tranche saw the conversion of another 5,20,000 warrants on May 29, 2026. The final tranche involved the conversion of 4,00,000 warrants on May 30, 2026.
Following these conversions, Bilcare Limited retains a balance of 5,80,000 convertible warrants. The disclosures were made to the Board of Directors of Caprihans India Limited on June 1, 2026, in compliance with Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Transaction Values
The total value of the shares acquired through these conversions was derived from the issue price of ₹200 per warrant. For the first two tranches of 5,20,000 shares each, the transaction value amounted to ₹10,40,00,000. For the third tranche of 4,00,000 shares, the transaction value was ₹8,00,00,000. The value represents 100% of the issue price, with 25% paid at the time of warrant allotment and the remaining 75% paid at the time of conversion into equity shares.
Historical Stock Returns for Caprihans
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.66% | +5.17% | +3.60% | -21.69% | -42.34% | -34.21% |
What are Bilcare Limited's strategic intentions for the remaining 5,80,000 convertible warrants?
How will the increased promoter holding influence Caprihans India's governance and future strategic decisions?
Is Caprihans India likely to pursue delisting given the promoter's strengthened position above the 60% threshold?

































